STEAP4 and neoplasm: Notably, STEAP4 deficiency resulted in decreased gross tumor growth (Fig. 1A), reduced tumor number (Fig. 1B), fewer tumors at specific sizes (1–2 mm and 3–4 mm; Fig. 1C) and diminished tumor burden (Fig. 1D).